Clinical Trial Update: Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating flavopiridol in combination with paclitaxel for locally advanced or metastatic esophageal cancer that has progressed after pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Flavopiridol (alvocidib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED